Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Kwon, Seok J ^a   Lee, Geun T ^a   Lee, Jae Ho ^a   Kim, Wun J ^b   Kim, Isaac Y ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Chungbuk National University   (South Korea)

Author keywords

Bone morphogenetic proteins; Inducible nitric oxide synthase; Interleukin 1 ; Macrophages; Nuclear factor kappa B; Smads

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CYCLOHEXIMIDE; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BONE MORPHOGENETIC PROTEIN 6; CELLS, CULTURED; CYCLOHEXIMIDE; DACTINOMYCIN; HUMANS; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN SYNTHESIS INHIBITORS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68249162072     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03079.x     Document Type: Article

References (27)

1. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988 242 : 1528 34.
2. Sampath TK, Maliakal JC, Hauschka PV et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992 267 : 20352 62.
3. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996 10 : 1580 94.
4. Zhao GQ. Consequences of knocking out BMP signaling in the mouse. Genesis 2003 35 : 43 56.
5. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005 16 : 251 63.
6. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci USA 1980 77 : 3494 8.
7. Kulkarni AB, Huh CG, Becker D et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993 90 : 770 4.
8. Yaswen L, Kulkarni AB, Fredrickson T et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 1996 87 : 1439 45.
9. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol 2005 6 : 9.
10. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E. BMP-6 inhibits human bone marrow B lymphopoiesis - upregulation of Id1 and Id3. Exp Hematol 2006 34 : 72 81.
11. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur J Immunol 2007 37 : 2937 48.
12. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003 384 : 1343 64.
13. Jung F, Palmer LA, Zhou N, Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 2000 86 : 319 25.
14. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982 126 : 131 8.
15. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004 500 : 255 66.
16. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005 19 : 2783 810.
17. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 1987 166 : 571 6.
18. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988 334 : 260 2.
19. Forstermann U, Schmidt HH, Kohlhaas KL, Murad F. Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-beta. Eur J Pharmacol 1992 225 : 161 5.
20. Ohguchi M, Yamato K, Ishihara Y et al. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 1998 18 : 491 8.
21. Zhang XJ, Li Y, Tai GX, Xu GY, Zhang PY, Yang Y, Lao FX, Liu ZH. Effects of activin A on the activities of the mouse peritoneal macrophages. Cell Mol Immunol 2005 2 : 63 7.
22. Apte RN, Dotan S, Elkabets M et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006 25 : 387 408.
23. Teng X, Zhang H, Snead C, Catravas JD. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 2002 282 : C144 52.
24. Shibuya H, Iwata H, Masuyama N et al. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 1998 17 : 1019 28.
25. Goswami M, Uzgare AR, Sater AK. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm. Dev Biol 2001 236 : 259 70.
26. Jadrich JL, O'Connor MB, Coucouvanis E. Expression of TAK1, a mediator of TGF-beta and BMP signaling, during mouse embryonic development. Gene Expr Patterns 2003 3 : 131 4.
27. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001 412 : 346 51.